Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$2.0B
77M shares
52-week range
$16.10 – $33.07
58% from low
Sector
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Exchange
NASDAQ
CS
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
www.progyny.comNo one on the platform currently holds PGNY.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 812,067 | $13.8M |
| Bridgewater Associatesas of 2025-09-30 | 65,643 | $1.4M |
No one on the platform has traded PGNY yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$PGNY Seems like the numbers get ignored and people just base off feelings around here. Heres the crux of it. Profit margin: Up from the 20-23% we saw all of '22 thru '25 to over 25% 📈 Outstanding Diluted Shares: Down to 82 mil from 90 mil in Q3 2025 a nearly 10% drop in outstanding shares in less than 1 year. 📈 Covered Lives: Projected to grow by 1 mil next year a 13% increase over the current 7.185 mil 📈 This company has 0 debt, is returning value to shareholders, and is improving in all important metrics they can control. If you dont have the time horizon of a retiree this is an obvious buy.
View on StockTwits ↗$LKNCY was speaking to guy who holds $PGNY like me after he posted about the $BROS drop being unfair like how we were hit after er yesterday on $PGNY . I told him that $BROS drop was fair b/c $LKNCY is king & will show it soon once off OTC. He laughed at me, saying he made better investment, so here’s hoping we have last laugh. Let’s go luckin I want to be the one laughing last & loudest🤞🙏👍.
View on StockTwits ↗$PGNY we’re recovering a bit. Hope to get back every penny that dropped yesterday before close. 🙏🤞
View on StockTwits ↗$PGNY this name has been pretty predictable around earnings...hold your shares, take out puts before earnings, roll those put profits to buy the dip after earnings
View on StockTwits ↗$PGNY Overreaction here, but not surprising. 60% run over the last 3 months and 335 million projected for Q3 (after reporting 350 million in Q2) shows slowed growth, but we here know that's a seasonal factor. Business is good, numbers are good, clients added daily... know what you hold and take these opportunities to buy
View on StockTwits ↗@Breakthewallsdown23 $BROS is justified as they’re not $LKNCY , but us here at $PGNY you’re 💯
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-8-6-progyny-inc-stock/ $PGNY Progyny Earnings Transcript
View on StockTwits ↗$PGNY this and tbe $BROS drop are the most ridiculous ive seen in a while
View on StockTwits ↗$PGNY absolutely comical takedown for providing an updated guide that is 3 pennies lower 😂😂 great quarter. Would have liked to see more shares repurchased, maybe they will now with a 20% haircut
View on StockTwits ↗$PGNY Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.36 up 80.00% YoY • Reported revenue of $350.51M up 5.30% YoY • Progyny, Inc. projects full year 2026 revenue of $1.360 billion to $1.385 billion, with third quarter 2026 revenue projected to be $335.0 million to $345.0 million, reflecting anticipated seasonal member engagement impacts.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.4B | +8.3% | $1.29 | $1.28–$1.30 | 20.1× | 6 |
| 2027 | $1.5B | +8.8% | $1.49 | $1.49–$1.50 | 17.3× | 6 |
| 2028 | $1.6B | +4.9% | $1.64 | $1.35–$1.84 | 15.8× | 3 |
| 2029 | $1.7B | +7.4% | $1.97 | $1.91–$2.03 | 13.2× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $0.33 | $0.36 | +7.5% |
| 2026-05-07 | $0.26 | $0.30 | +17.2% |
| 2026-02-26 | $0.15 | $0.15 | +2.0% |
| 2025-11-06 | $0.39 | $0.45 | +15.4% |
| 2025-08-07 | $0.44 | $0.48 | +9.1% |
| 2025-05-08 | $0.45 | $0.48 | +6.7% |
| 2025-02-27 | $0.37 | $0.42 | +13.5% |
| 2024-11-12 | $0.37 |
| $0.40 |
| +8.1% |
| $1.4B |
| — |
| PHRPhreesia, Inc. | $12.62 | +2.94% | $780M | — |
| SDGRSchrödinger, Inc. | $18.46 | -0.91% | $1.4B | — |
Source: Financial Modeling Prep · peers by sector/industry